{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:35:52Z","timestamp":1790883352793,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011736","name":"State Ministry of Baden-Wuerttemberg for Economic Affairs Labour and Housing Construction","doi-asserted-by":"publisher","award":["BW1_4064\/02"],"award-info":[{"award-number":["BW1_4064\/02"]}],"id":[{"id":"10.13039\/501100011736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["SA 2676\/3-1"],"award-info":[{"award-number":["SA 2676\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004189","name":"Max-Planck-Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002345","name":"Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"DZIF","doi-asserted-by":"publisher","award":["TTU03.820"],"award-info":[{"award-number":["TTU03.820"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ijid.2025.107990","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:49:52Z","timestamp":1752713392000},"page":"107990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Class switch toward IgG2 and IgG4 is more pronounced in BNT162b2 compared to mRNA-1273 COVID-19 vaccinees"],"prefix":"10.1016","volume":"159","author":[{"given":"Alex S.","family":"Siebner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Griesbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey E.","family":"Huus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Fl\u00fcgge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Hopfensperger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Schneiderhan-Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Kremsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth E.","family":"Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Dulovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral","family":"Esen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.107990_bib0001","unstructured":"RKI. Empfehlungen der STIKO zur COVID-19-Impfung: Epidemiologisches Bulletin, 2022."},{"key":"10.1016\/j.ijid.2025.107990_bib0002","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2025.107990_bib0003","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/vaccines11050991","article-title":"IgG4 antibodies induced by repeated vaccination may generate immune tolerance to the SARS-CoV-2 spike protein","volume":"11","author":"Uversky","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijid.2025.107990_bib0004","doi-asserted-by":"crossref","first-page":"eade2798","DOI":"10.1126\/sciimmunol.ade2798","article-title":"Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination","volume":"8","author":"Irrgang","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ijid.2025.107990_bib0005","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3390\/v15040970","article-title":"Comparison of kinetics of antibody avidity and IgG subclasses' response in patients with COVID-19 and healthy individuals vaccinated with the BNT162B2 (Comirnaty, Pfizer\/BioNTech) mRNA vaccine","volume":"15","author":"Rastawicki","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ijid.2025.107990_bib0006","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40103-x","article-title":"Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history","volume":"13","author":"Kiszel","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2025.107990_bib0007","doi-asserted-by":"crossref","first-page":"eabm2311","DOI":"10.1126\/scitranslmed.abm2311","article-title":"mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions","volume":"14","author":"Kaplonek","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijid.2025.107990_bib0008","article-title":"mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine","volume":"13","author":"Buhre","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2025.107990_bib0009","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/vaccines13020123","article-title":"Immunosuppressive therapy modifies anti-spike IgG subclasses distribution after four doses of mRNA vaccination in a cohort of kidney transplant recipients","volume":"13","author":"Juarez","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijid.2025.107990_bib0010","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/all.16241","article-title":"Anti-TNF therapy impairs both short- and long-term IgG responses after repeated vaccination","volume":"80","author":"Buhre","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.ijid.2025.107990_bib0011","unstructured":"\u00b5HEAT Clinical Group Huus K.E., Tan Y.H., Abo H., Keller R., Atay E., et al. Flagellin in the human gut microbiome is a diet-adjustable adjuvant for vaccination. 17 June 2025. https:\/\/www.biorxiv.org\/content\/10.1101\/2025.02.21.639485; 2025."},{"key":"10.1016\/j.ijid.2025.107990_bib0012","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1038\/s41467-021-23473-6","article-title":"Immune response to SARS-CoV-2 variants of concern in vaccinated individuals","volume":"12","author":"Becker","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijid.2025.107990_bib0013","doi-asserted-by":"crossref","first-page":"eadg7327","DOI":"10.1126\/sciimmunol.adg7327","article-title":"Is it bad, is it good, or is IgG4 just misunderstood?","volume":"8","author":"Pillai","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ijid.2025.107990_bib0014","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12979-024-00466-9","article-title":"Repeated COVID-19 mRNA vaccination results in IgG4 class switching and decreased NK cell activation by S1-specific antibodies in older adults","volume":"21","author":"Gelderloos","year":"2024","journal-title":"Immun Ageing"},{"key":"10.1016\/j.ijid.2025.107990_bib0015","doi-asserted-by":"crossref","unstructured":"Biswal M.R., Roy S., Singh JK. Comparative analysis of lipid nanoparticles in Pfizer-BioNTech and moderna COVID-19 vaccines: insights from Molecular Dynamics simulations bioRxiv. 04 October. 17 June, 2025. https:\/\/www.biorxiv.org\/content\/10.1101\/2024.10.04.616619; 2024.","DOI":"10.1101\/2024.10.04.616619"},{"key":"10.1016\/j.ijid.2025.107990_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111953","article-title":"Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2","volume":"142","author":"Granados-Riveron","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ijid.2025.107990_bib0017","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/vaccines10071057","article-title":"mRNA booster vaccination enhances antibody responses against SARS-CoV2 omicron variant in individuals primed with mRNA or inactivated virus vaccines","volume":"10","author":"Zhang","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijid.2025.107990_bib0018","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/v16020187","article-title":"The anti-SARS-CoV-2 IgG1 and IgG3 antibody isotypes with limited neutralizing capacity against omicron elicited in a Latin population a switch toward IgG4 after multiple doses with the mRNA Pfizer-BioNTech vaccine","volume":"16","author":"Espino","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.ijid.2025.107990_bib0019","doi-asserted-by":"crossref","first-page":"228ra38","DOI":"10.1126\/scitranslmed.3007736","article-title":"Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines","volume":"6","author":"Chung","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijid.2025.107990_bib0020","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1089\/aid.2016.0204","article-title":"Comparison of antibody responses induced by RV144, VAX003, and VAX004 vaccination regimens","volume":"33","author":"Karnasuta","year":"2017","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.ijid.2025.107990_bib0021","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/CVI.05523-11","article-title":"Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children","volume":"19","author":"Doba\u00f1o","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.ijid.2025.107990_bib0022","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3390\/vaccines10020136","article-title":"Age and primary vaccination background influence the plasma cell response to pertussis booster vaccination","volume":"10","author":"Diks","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijid.2025.107990_bib0023","doi-asserted-by":"crossref","first-page":"267","DOI":"10.37349\/ei.2024.00140","article-title":"Exploring the possible link between the spike protein immunoglobulin G4 antibodies and cancer progression","volume":"4","author":"Raszek","year":"2024","journal-title":"Explor Immunol"},{"key":"10.1016\/j.ijid.2025.107990_bib0024","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3390\/cancers17122006","article-title":"Repeated COVID-19 vaccination as a poor prognostic factor in pancreatic cancer: a retrospective, single-center cohort study","volume":"17","author":"Abue","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.ijid.2025.107990_bib0025","doi-asserted-by":"crossref","first-page":"eads1482","DOI":"10.1126\/sciadv.ads1482","article-title":"Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variant","volume":"11","author":"Aurelia","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.ijid.2025.107990_bib0026","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/M21-3256","article-title":"COVID-19 vaccination effectiveness against infection or death in a national U.S. health care system: a target trial emulation study","volume":"175","author":"Ioannou","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijid.2025.107990_bib0027","article-title":"Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections","volume":"90","author":"P\u00e9rez","year":"2025","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2025.107990_bib0028","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1056\/NEJMoa2114114","article-title":"Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar","volume":"385","author":"Chemaitelly","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2025.107990_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0293449","article-title":"Risk of coronavirus disease 2019 (COVID-19) among those up-to-date and not up-to-date on COVID-19 vaccination by US CDC criteria","volume":"18","author":"Shrestha","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2025.107990_bib0030","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.2023.27022","article-title":"Effectiveness of bivalent mRNA COVID-19 vaccines in preventing SARS-CoV-2 infection in children and adolescents aged 5 to 17 years","volume":"331","author":"Feldstein","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2025.107990_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106119","article-title":"Altered IgG4 antibody response to repeated mRNA versus recombinant protein SARS-CoV-2 vaccines","volume":"88","author":"Kalkeri","year":"2024","journal-title":"J Infect"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225002140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225002140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:28:09Z","timestamp":1772882889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225002140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":31,"alternative-id":["S1201971225002140"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.107990","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Class switch toward IgG2 and IgG4 is more pronounced in BNT162b2 compared to mRNA-1273 COVID-19 vaccinees","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.107990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107990"}}